Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade.
about
Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade.Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma.Immunotherapy for Pediatric Brain Tumors.Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.Current state and future prospects of immunotherapy for glioma.Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models.Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization.PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.Immune Microenvironment in Glioblastoma Subtypes.Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma.Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples.Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus.A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumorsOncolytic Viruses as Therapeutic Tools for Pediatric Brain TumorsIL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factorsOncolytic virus and PD-1/PD-L1 blockade combination therapyModifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2
P2860
Q42364948-51A2869C-F572-4B55-8DB3-DB17F4B62EA7Q44243239-C61A21BB-5AA6-444A-BDC5-0DEA7CB3AF84Q46407536-DF36CFFB-A254-4461-9388-1FCCB254E2B9Q47365404-310F310A-58E0-4C38-BCE2-C123C17B0E39Q50109459-F22D495B-EA44-4A3E-B3BC-73BFC92314DAQ52337612-B0B1448C-8C01-4C17-863B-B569802DEFE6Q52666797-413D370B-8914-474C-B9B4-8BB72105B007Q52674215-32C3F4F2-4BA1-4C8A-9FC8-99E395FC21AEQ53697047-95FCB1C0-E2A4-42A5-B8ED-7C68987520BEQ55261256-3B2F0C29-0FB8-4082-886A-2A062054DEF3Q55456543-6854AE21-B2BA-4E78-9E33-A432D1A3CE36Q55456984-FA86D661-412E-489C-97FC-9112CCC47D36Q55457206-56C238E5-45F4-4464-B641-0421585DDA56Q55492485-67E1CC71-540C-47D0-BA84-D9EBB42C05C2Q56348401-420E8F34-93CB-4DB2-93A4-013BF44C6925Q56892727-43ABEF88-B43B-48E2-AA44-53D706764E49Q57138348-F5A6C454-BCA9-48C1-A43A-DA3FFA3C2FBEQ57174025-D4A7C594-0FFC-4F16-B525-768AE09504C1Q58586410-DF26DBBD-93FD-4A6F-BE93-73D2A4FC86BC
P2860
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Macrophage Polarization Contri ...... nd Immune Checkpoint Blockade.
@en
type
label
Macrophage Polarization Contri ...... nd Immune Checkpoint Blockade.
@en
prefLabel
Macrophage Polarization Contri ...... nd Immune Checkpoint Blockade.
@en
P2860
P1433
P1476
Macrophage Polarization Contri ...... nd Immune Checkpoint Blockade.
@en
P2093
Dipongkor Saha
P2860
P304
253-267.e5
P356
10.1016/J.CCELL.2017.07.006
P577
2017-08-01T00:00:00Z